DailyStocks Stock Article Search

https://www.fool.com/investing/2020/04/30/heres-why-investors-should-follow-sanofi-and-glaxo.aspx?source=iedfolrf0000001 Apr 30, 2020 - The combined effort of these two companies marks one of the largest manufacturing collaborations on the planet toward a coronavirus vaccine. 0

http://www.zacks.com/stock/news/900968/sny-vs-nvo-which-stock-is-the-better-value-option?cid=CS-ZC--tale_of_the_tape|yseop_template_3-900968 Apr 30, 2020 - SNY vs. NVO: Which Stock Is the Better Value Option? 0

http://www.zacks.com/stock/news/899331/healthcare-etfs-to-gain-on-progress-in-coronavirus-vaccine?cid=CS-ZC-FT-etf_news_and_commentary-899331 Apr 29, 2020 - The healthcare space is heated up with players rushing to come up with a vaccine for COVID-19. 0

http://www.zacks.com/stock/news/897526/the-zacks-analyst-blog-highlights-moderna-johnson-johnson-sanofi-and-novavax?cid=CS-ZC-FT-press_releases-897526 Apr 29, 2020 - The Zacks Analyst Blog Highlights: Moderna, Johnson & Johnson, Sanofi and Novavax 0

http://www.zacks.com/stock/news/898431/is-a-beat-in-store-for-amarin-amrn-this-earnings-season?cid=CS-ZC-FT-analyst_blog|earnings_preview-898431 Apr 29, 2020 - Amarin's (AMRN) first-quarter results are likely to reflect strong demand for its cardiovascular drug, Vascepa. 0

http://www.zacks.com/stock/news/894160/should-value-investors-buy-sanofi-sny-stock?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_2-894160 Apr 28, 2020 - Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. 0

http://www.zacks.com/stock/news/894002/3-stocks-to-benefit-from-race-to-develop-coronavirus-vaccines?cid=CS-ZC-FT-analyst_blog|investment_ideas-894002 Apr 28, 2020 - Pharmaceutical companies and scientists are relentlessly working on developing coronavirus vaccines and the progress in trails has helped stocks to rally. 0

https://www.fool.com/investing/2020/04/27/positive-cancer-trial-results-offset-a-covid-19-fl.aspx?source=iedfolrf0000001 Apr 27, 2020 - The companies shared good news about lung cancer patients treated with Libtayo, and bad news about a potential treatment for COVID-19. 0

https://www.fool.com/investing/2020/04/27/regeneron-sanofi-say-kevzara-will-now-only-be-test.aspx?source=iedfolrf0000001 Apr 27, 2020 - The companies are halting clinical studies of the drug in those with severe cases of COVID-19 and focusing only on critical patients. 0

http://www.zacks.com/stock/news/891794/big-drug-stock-q1-earnings-due-on-apr-28-mrk-pfe-and-nvs?cid=CS-ZC-FT-analyst_blog:_earnings_preview_-_esp|earnings_preview_-_esp-891794 Apr 27, 2020 - Let us take a look at three big drug companies due to release their first-quarter financial results on Apr 28. 0